Fluoroquinolone Use Preceding Visceral Artery Dissection: A Case Series.

dissection fluoroquinolones medium-sized arteries

Journal

Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706

Informations de publication

Date de publication:
19 Oct 2023
Historique:
medline: 19 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: aheadofprint

Résumé

Fluoroquinolones (FQ), commonly prescribed antibiotics, may trigger aortic and carotid dissections. We report three successive cases of visceral artery dissection: one patient with celiac trunk dissection and two with dissection of the superior mesenteric artery. These events occurred up to 4 months after 7 to 14 days of FQ treatment (2 cases of ofloxacin, 1 of norfloxacin). There was no other apparent cause of dissection. These dissections were isolated, apart from a minimal aortic dissection separate from the visceral arterial dissection in one case. A case series cannot certify the relationship between dissection and FQ, but it can be hypothesized. The association between fluoroquinolone use and higher occurrence of aneurysm and dissection remains discussed in aortic syndrome. The potential link between FQ and visceral artery dissection is even less described but should be reported in the absence of previous cases in the literature. The pathophysiological theory is the induction of overexpression of some matrix metalloproteinases and a decrease of their inhibitors, provoking a dysregulation in collagen synthesis and degradation of the extracellular matrix.

Identifiants

pubmed: 37855079
doi: 10.1177/00033197231207945
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33197231207945

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Louise Z Wang (LZ)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.

Boris Oehmichen (B)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.

Benjamin Pariente (B)

Hypertension Center, Georges Pompidou European Hospital, APHP, Paris, France.

Nassim Mohamedi (N)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.

Charles Cheng (C)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.

Grégoire Detriche (G)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.

Alexandre Galloula (A)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.

Agnès Lilo Le Louet (A)

Pharmacovigilance Center, Georges Pompidou European Hospital, APHP, Paris, France.

Emmanuel Messas (E)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Laurence Amar (L)

Hypertension Center, Georges Pompidou European Hospital, APHP, Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Guillaume Goudot (G)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Tristan Mirault (T)

Vascular Medicine Department, Georges Pompidou European Hospital, APHP, Paris, France.
Université Paris Cité, INSERM U970 PARCC, Paris, France.

Classifications MeSH